Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
960.00    24.00 (2.56%)
Bid:
932.00
Ask:
944.00
Spread: 12.00 (1.288%)
Market Cap: £262.76m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Full-Year Trading Update

4 Oct 2011 07:00

RNS Number : 4702P
Gooch & Housego PLC
04 October 2011
 



 

For immediate release

4 October 2011

 

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Full-Year Trading Update

 

Gooch & Housego PLC, the specialist manufacturer of optical components & systems, today announces that results for the year ended 30 September 2011will be in line with market expectations. Preliminary results will be announced on 29 November 2011.

 

Favourable market conditions prevailed for the first three quarters of the year and strong demand was experienced across most market and product sectors. The acquisitions of EM4 and Crystal Technology during the second quarter contributed to revenue and profit growth and accelerated the diversification of the business. G&H's presence in the aerospace & defence, life sciences and telecommunications markets has been significantly enhanced, while the Company's market leadership in acousto-optics and electro-optics for industrial applications has also been reinforced. Given the fragile global economic environment we did anticipate some softening in demand in the final quarter, although this has been confined to certain product sectors and geographical markets. Greater diversification and growth in new markets has mitigated some of the effects of the slowing demand in other sectors.

 

The integration of the new acquisitions is progressing well. The rationale for G&H's acquisition of EM4 was demonstrated by a number of significant contract wins for strategic defence programs including the recent award of a $3+ million contract by a large US defence contractor for the first phase of the design, development and supply of fibre optic systems. Plans to duplicate G&H Torquay's passive fibre optics technology at EM4's Boston site, in order to access the large US aerospace & defence market for these products, are already well-advanced with the first products expected to be available for qualification testing in early 2012.

 

Crystal Technology has performed strongly during the first six months of G&H ownership, with revenues from all major markets exceeding original plan. The transfer of crystal growing from the Crystal Technology facility in Palo Alto to G&H's Cleveland operation - a major undertaking requiring the fitting out of a new 30,000 square foot facility - is making good progress. The facility is essentially complete and the first crystals have been grown. It is expected that production will be fully transferred by the end of the calendar year.

 

Gareth Jones, Chief Executive of Gooch & Housego commented: -

 

"During the past twelve months we have made progress towards achieving the key strategic and commercial objectives of greater diversification and strong organic and acquisitive growth. The uncertain economic climate will present challenges in the coming year but Gooch & Housego is well-positioned to deliver the next phase of its strategy as we seek to leverage the exceptional products, technologies and capabilities that the company now has to offer."

 

For further information please contact:

 

Gareth Jones/Andrew Boteler, 01460 256440

Tim Thompson/Nicola Cronk, Buchanan, 020 7466 5000

Patrick Robb/James Grace, Investec Bank plc, 020 7597 5970

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFSDFMDFFSEDS
Date   Source Headline
23rd Jul 20127:00 amRNSProgress Update
12th Jun 20127:00 amRNSInterim Results
22nd May 20127:00 amRNSNotification of Interim Results
5th Apr 20127:00 amRNSHalf-Year Trading Update
14th Mar 20128:59 amRNSAIM Rule 20 - Annual Report
23rd Feb 201212:45 pmRNSAppointment of non-executive director
23rd Feb 20127:00 amRNSResults of Annual General Meeting
21st Feb 20127:00 amRNSTrading Update
29th Nov 20117:00 amRNSPreliminary Results
4th Nov 20114:35 pmRNSPrice Monitoring Extension
4th Oct 20117:00 amRNSFull-Year Trading Update
29th Sep 201111:52 amRNSBoard Change
8th Jun 20117:00 amRNSInterim Results
12th May 201112:24 pmRNSNotice of Results
1st Apr 20117:00 amRNSAcquisition and Trading Update
23rd Feb 20117:00 amRNSProgress Update for Today's Annual General Meeting
28th Jan 20118:10 amRNSDirector/PDMR Shareholding
25th Jan 20118:30 amRNSAcquisition of EM4
24th Jan 201112:07 pmRNSAdditional Listing
19th Jan 201111:45 amRNSUS Regulatory Approval
13th Jan 20114:55 pmRNSNotification of Interests
13th Jan 20114:55 pmRNSDirector Shareholdings
13th Jan 20114:53 pmRNSAdditional Listing
5th Jan 20111:42 pmRNSResult of EGM
16th Dec 20102:37 pmRNSProposed Acquisition, Placing and General Meeting
2nd Dec 20108:52 amRNSDividend
30th Nov 20107:00 amRNSPreliminary Results
15th Nov 20107:00 amRNSNotice of Results
5th Oct 20107:00 amRNSFull-Year Trading Update
17th Sep 20102:26 pmRNSHolding(s) in Company
13th Jul 20107:00 amRNSTrading Update
8th Jun 20107:00 amRNSInterim Results
18th May 20107:00 amRNSNotice of Results
8th Apr 20107:00 amRNSHalf-Year Trading Update
26th Mar 20103:33 pmRNSHolding(s) in Company
12th Mar 20108:56 amRNSDirector/PDMR Shareholding
25th Feb 201011:00 amRNSResult of AGM
24th Feb 20107:00 amRNSProgress Update for Today's Annual General Meeting
26th Jan 20108:24 amRNSDirector/PDMR Shareholding
18th Jan 20103:48 pmRNSAward of Share Options
7th Jan 20103:09 pmRNSAward of share-based incentives
1st Dec 20097:00 amRNSPreliminary Results
12th Nov 20098:56 amRNSNotice of Results
6th Oct 20097:00 amRNSFull-Year Trading Update
23rd Jul 20097:00 amRNSAppointment of new executive director
9th Jun 20097:00 amRNSInterim Results
13th May 20098:57 amRNSNotice of Results
2nd Apr 20097:00 amRNSResult of AGM
31st Mar 20097:00 amRNSHalf-Year Trading Update
23rd Mar 20097:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.